Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2024-06-26 Regulatory Filings
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Solco Biomedical regarding the setting of a record date for an upcoming Extraordinary General Meeting of shareholders. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the record date for shareholder rights. Given it is a regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2024-06-26 Korean
[첨부추가]주주총회소집결의
AGM Information Classification · 95% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for Solco Biomedical, detailing the date, location, and agenda items (capital reduction and articles of association amendment). This type of document is a standard proxy solicitation or meeting notice sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2024-06-26 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a decision on a paid-in capital increase (유상증자결정) and a subsequent amendment (정정신고) to that report. It details the issuance of new shares to a third party (MDS Tech) and the resulting change in the company's largest shareholder. This falls under the category of share issuance and capital structure changes.
2024-06-25 Korean
[기재정정]경영권변경등에관한계약체결
M&A Activity Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a 'Change in Management Control' (경영권 변경 등에 관한 계약 체결). It details changes to the terms of a previously announced contract, including updates to the payment schedule, the identity of the acquiring entity, and the resulting change in the company's largest shareholder. As this is a formal regulatory disclosure of a material corporate event (change in control/ownership structure) that does not fit into specific categories like M&A (which usually refers to full mergers/acquisitions) or Director's Dealing, it is classified as a general Regulatory Filing (RNS).
2024-06-25 Korean
증권발행결과(자율공시) (제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by Solco Biomedical. It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2024-06-25 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a change in the company's largest shareholder (최대주주변경). It details the transition from the previous major shareholders to a new corporate entity (MDS Tech) following a third-party capital increase. This type of disclosure is a standard regulatory announcement regarding corporate structure and ownership changes, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is typically for external investors reporting their own holdings).
2024-06-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.